Gabapentin-Mepha 100 mg

Gabapentin-Mepha 100 mg is a medicine authorised by Swissmedic under authorisation number 57777. The authorisation holder is Mepha Pharma AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 14 August 2008 and the authorisation is valid without a time limit. ATC code N02BF01 places the medicine in the group Analgesics.

  • Dispensing category B
  • Authorisation number 57777
  • ATC N02BF01
  • Synthetic medicines
Authorisation data
Authorisation number57777
NameGabapentin-Mepha 100 mg
Full nameGabapentin-Mepha 100 mg, Hartkapseln
Authorisation holderMepha Pharma AG
Medicinal product codeSynthetic medicines
Dispensing categoryB · Prescription only
ATC codeN02BF01
First authorisation14 August 2008
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Gabapentin-Mepha 100 mg, HartkapselnB14 August 2008
2Gabapentin-Mepha 300 mg, HartkapselnB14 August 2008
3Gabapentin-Mepha 400 mg, HartkapselnB14 August 2008

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
1350Kapsel(n)N02BF0101.07.1.B
14100Kapsel(n)N02BF0101.07.1.B
1550Kapsel(n)N02BF0101.07.1.B
16100Kapsel(n)N02BF0101.07.1.B
1750Kapsel(n)N02BF0101.07.1.B
18100Kapsel(n)N02BF0101.07.1.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Gabapentin-Mepha 100 mg authorised in Switzerland?

Yes. Gabapentin-Mepha 100 mg is authorised by Swissmedic under authorisation number 57777, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Gabapentin-Mepha 100 mg have?

Gabapentin-Mepha 100 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Gabapentin-Mepha 100 mg?

The authorisation holder is Mepha Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com